CorMatrix Cardiovascular Release: Improvement In Cardiac Function With Particulate ECM Alone And Adjunct To LVAD Demonstrated In Bovine Model

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN DIEGO--(BUSINESS WIRE)--New research presented Sunday at the 34th Annual meeting of the International Society for Heart and Lung Transplantation (ISHLT) demonstrated the CorMatrix particulate extracellular matrix (P-ECM) alone and as an adjunct to HeartWare International Inc.’s left ventricular assist device (LVAD) improved cardiac function in a bovine ischemic heart failure model, as compared to LVAD alone. Mark S. Slaughter, M.D., of the Department of Cardiovascular and Thoracic Surgery and his research team from the University of Louisville, Louisville, KY, presented data during the ISHLT Mechanical Circulatory Support: Bench to Bedside Session in his presentation entitled “Myocardial Regeneration and Recovery with Extracellular Matrix and LVAD Support” on Sunday Morning.

Help employers find you! Check out all the jobs and post your resume.

Back to news